参考文献:桑多安发表了哪些科学论文?
阅读:789次 更新时间:2021-01-14
1. Li et al., 2018. Safety evaluation of mulberry leaf extract: acute, subacute toxicity and genotoxicity studies. Regulatory Toxicology and Pharmacology; 95: 220-226
2. Marx et al, 2016. 28-day repeat dose toxicological study of an aqueous extract on Morus alba. L. International Journey of Toxicity.
3. Liu et al, 2016. Prevention effects and possible molecular mechanism of mulberry leaf extract and its formulation on rats with insulin sensitivity. PLOS ONE 11(4): e0152728.
4. Lown et al, 2015. Mulberry extract to modulate Blood glucose Responses in normoglycaemic adults (MULBERRY) study protocol. Trial 16:486
5. Lown et al, 2017. Mulberry extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: results of a randomized double-blind placebo controlled study. PLOS ONE pone0172239
6. Wang et al, 2018. Mulberry leaf extract reduces the glycemic indexes of four common dietary carbohydrates. Medicine 97:34(e11996)
7. SUGERS study: Clinical Study to assess the Glycaemic Effect of Reducose on a Sucrose challenge: a double blind, placebo controlled, crossover clinical trial
2. Marx et al, 2016. 28-day repeat dose toxicological study of an aqueous extract on Morus alba. L. International Journey of Toxicity.
3. Liu et al, 2016. Prevention effects and possible molecular mechanism of mulberry leaf extract and its formulation on rats with insulin sensitivity. PLOS ONE 11(4): e0152728.
4. Lown et al, 2015. Mulberry extract to modulate Blood glucose Responses in normoglycaemic adults (MULBERRY) study protocol. Trial 16:486
5. Lown et al, 2017. Mulberry extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: results of a randomized double-blind placebo controlled study. PLOS ONE pone0172239
6. Wang et al, 2018. Mulberry leaf extract reduces the glycemic indexes of four common dietary carbohydrates. Medicine 97:34(e11996)
7. SUGERS study: Clinical Study to assess the Glycaemic Effect of Reducose on a Sucrose challenge: a double blind, placebo controlled, crossover clinical trial